|
|||||
|
|
Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro |
|
| Authors: | Z Hao D A Cooney N R Hartman C F Perno A Fridland A L DeVico M G Sarngadharan S Broder D G Johns |
| Institution: | Developmental Therapeutics Program, National Cancer Institute, Bethesda, Maryland 20892. |
| Abstract: | |
| Keywords: | |